| Old | New | Differences | |
|---|---|---|---|
| 1 | 1 | ||
| 2 | 2 | ||
| 3 | 3 | EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW. | |
| 4 | 4 | [Brackets] indicate matter deleted from existing law. | |
| 5 | - | Underlining indicates amendments to bill. | |
| 6 | - | Strike out indicates matter stricken from the bill by amendment or deleted from the law by | |
| 7 | - | amendment. | |
| 8 | 5 | *hb1004* | |
| 9 | 6 | ||
| 10 | 7 | HOUSE BILL 1004 | |
| 11 | 8 | J1 5lr2242 | |
| 12 | 9 | CF SB 748 | |
| 13 | - | By: Delegate Martinez Delegates Martinez, Alston, Bagnall, Bhandari, Cullison, | |
| 14 | - | Guzzone, Hill, Hutchinson, S. Johnson, Kaiser, Kerr, Kipke, Lopez, | |
| 15 | - | Pena–Melnyk, Reilly, Rosenberg, Ross, Taveras, White Holland, Woods, and | |
| 16 | - | Woorman | |
| 10 | + | By: Delegate Martinez | |
| 17 | 11 | Introduced and read first time: January 31, 2025 | |
| 18 | 12 | Assigned to: Health and Government Operations | |
| 19 | - | Committee Report: Favorable with amendments | |
| 20 | - | House action: Adopted | |
| 21 | - | Read second time: March 6, 2025 | |
| 22 | 13 | ||
| 23 | - | ||
| 14 | + | A BILL ENTITLED | |
| 24 | 15 | ||
| 25 | 16 | AN ACT concerning 1 | |
| 26 | 17 | ||
| 27 | 18 | Public Health – Alzheimer’s Disease and Related Dementias – Information on 2 | |
| 28 | 19 | Prevalence and Treatment 3 | |
| 29 | 20 | ||
| 30 | 21 | FOR the purpose of requiring the Maryland Department of Health, in partnership with 4 | |
| 31 | 22 | certain entities, to incorporate information regarding treatments approved by the 5 | |
| 32 | 23 | Food and Drug Administration for Alzheimer’s disease and related dementias and to 6 | |
| 33 | 24 | increase understanding and awareness of treatment of Alzheimer’s disease and 7 | |
| 34 | 25 | related dementias into relevant public health outreach programs administered by 8 | |
| 35 | 26 | the Department; requiring the Department to establish and maintain a website that 9 | |
| 36 | 27 | includes certain information on the prevalence and hospitalization rate of 10 | |
| 37 | 28 | Alzheimer’s disease and related dementias; and generally related to Alzheimer’s 11 | |
| 38 | 29 | disease and related dementias. 12 | |
| 39 | 30 | ||
| 40 | 31 | BY repealing and reenacting, with amendments, 13 | |
| 41 | 32 | Article – Health – General 14 | |
| 42 | 33 | Section 18–110 15 | |
| 43 | 34 | Annotated Code of Maryland 16 | |
| 44 | 35 | (2023 Replacement Volume and 2024 Supplement) 17 | |
| 45 | 36 | ||
| 46 | 37 | BY adding to 18 | |
| 47 | 38 | Article – Health – General 19 | |
| 48 | - | Section 18–111 20 2 HOUSE BILL 1004 | |
| 39 | + | Section 18–111 20 | |
| 40 | + | Annotated Code of Maryland 21 | |
| 41 | + | (2023 Replacement Volume and 2024 Supplement) 22 | |
| 42 | + | ||
| 43 | + | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 23 | |
| 44 | + | That the Laws of Maryland read as follows: 24 | |
| 45 | + | ||
| 46 | + | Article – Health – General 25 | |
| 47 | + | ||
| 48 | + | 18–110. 26 2 HOUSE BILL 1004 | |
| 49 | 49 | ||
| 50 | 50 | ||
| 51 | - | Annotated Code of Maryland 1 | |
| 52 | - | (2023 Replacement Volume and 2024 Supplement) 2 | |
| 53 | 51 | ||
| 54 | - | SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 3 | |
| 55 | - | That the Laws of Maryland read as follows: 4 | |
| 52 | + | The Department, in partnership with the Department of Aging, the Virginia I. Jones 1 | |
| 53 | + | Alzheimer’s Disease and Related Disorders Council, and the Greater Maryland Chapter of 2 | |
| 54 | + | the Alzheimer’s Association, shall incorporate information into relevant public health 3 | |
| 55 | + | outreach programs administered by the Department to: 4 | |
| 56 | 56 | ||
| 57 | - | ||
| 57 | + | (1) Educate health care providers regarding: 5 | |
| 58 | 58 | ||
| 59 | - | 18–110. 6 | |
| 59 | + | (i) The importance of early detection and timely diagnosis of 6 | |
| 60 | + | cognitive impairment; 7 | |
| 60 | 61 | ||
| 61 | - | The Department, in partnership with the Department of Aging, the Virginia I. Jones 7 | |
| 62 | - | Alzheimer’s Disease and Related Disorders DEMENTIAS Council, and the Greater 8 | |
| 63 | - | Maryland Chapter of the Alzheimer’s Association, shall incorporate information into 9 | |
| 64 | - | relevant public health outreach programs administered by the Department to: 10 | |
| 62 | + | (ii) Validated assessment tools for the detection and diagnosis of 8 | |
| 63 | + | cognitive impairment; 9 | |
| 65 | 64 | ||
| 66 | - | (1) Educate health care providers regarding: 11 | |
| 65 | + | (iii) The value of a Medicare annual wellness visit or other annual 10 | |
| 66 | + | physical for an individual at least 65 years old for cognitive health; [and] 11 | |
| 67 | 67 | ||
| 68 | - | ( | |
| 69 | - | cognitive impairment; 13 | |
| 68 | + | (iv) The Medicare care planning billing code for individuals with 12 | |
| 69 | + | cognitive impairment; and 13 | |
| 70 | 70 | ||
| 71 | - | ( | |
| 72 | - | ||
| 71 | + | (V) TREATMENTS APPROVED BY THE FOOD AND DRUG 14 | |
| 72 | + | ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATED DEMENTIA S; AND 15 | |
| 73 | 73 | ||
| 74 | - | (iii) The value of a Medicare annual wellness visit or other annual 16 | |
| 75 | - | physical for an individual at least 65 years old for cognitive health; [and] 17 | |
| 74 | + | (2) Increase understanding and awareness of: 16 | |
| 76 | 75 | ||
| 77 | - | ( | |
| 78 | - | ||
| 76 | + | (i) The early warning signs of Alzheimer’s disease and [other types 17 | |
| 77 | + | of dementia] RELATED DEMENTIA S; 18 | |
| 79 | 78 | ||
| 80 | - | (V) TREATMENTS APPROVED B Y THE FOOD AND DRUG 20 | |
| 81 | - | ADMINISTRATION FOR ALZHEIMER’S DISEASE AND R ELATED DEMENTIAS , 21 | |
| 82 | - | INCLUDING RELEVANT I NFORMATION ON TREATM ENT USE AND OUTCOMES ; AND 22 | |
| 79 | + | (ii) The value of early detection [and], diagnosis, AND TREATMENT 19 | |
| 80 | + | of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS; and 20 | |
| 83 | 81 | ||
| 84 | - | (2) Increase PUBLIC understanding and awareness of: 23 | |
| 82 | + | (iii) How to reduce the risk of cognitive decline, particularly among 21 | |
| 83 | + | individuals in Black and Latino communities who are at greater risk of developing 22 | |
| 84 | + | Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS. 23 | |
| 85 | 85 | ||
| 86 | - | (i) The early warning signs of Alzheimer’s disease and [other types 24 | |
| 87 | - | of dementia] RELATED DEMENTIAS ; 25 | |
| 86 | + | 18–111. 24 | |
| 88 | 87 | ||
| 89 | - | (ii) The value of early detection [and], diagnosis, AND TREATMENT 26 | |
| 90 | - | of Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS ; and 27 | |
| 88 | + | (A) THE DEPARTMENT , IN COLLABORATION WITH THE STATE–DESIGNATED 25 | |
| 89 | + | HEALTH INFORMATION E XCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY 26 | |
| 90 | + | ACCESSIBLE WEBSITE T HAT INCLUDES IN A DOWNLOADABLE FO RMAT THE 27 | |
| 91 | + | FOLLOWING INFORMATIO N: 28 | |
| 91 | 92 | ||
| 92 | - | (iii) How to reduce the risk of cognitive decline, particularly among 28 | |
| 93 | - | individuals in Black and Latino communities who are at greater risk of developing 29 | |
| 94 | - | Alzheimer’s disease and [other types of dementia] RELATED DEMENTIAS ; AND 30 | |
| 93 | + | (1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATE D 29 | |
| 94 | + | DEMENTIA S IN THE STATE; 30 | |
| 95 | 95 | HOUSE BILL 1004 3 | |
| 96 | 96 | ||
| 97 | 97 | ||
| 98 | - | (IV) TREATMENTS APPROVED B Y THE U.S. FOOD AND DRUG 1 | |
| 99 | - | ADMINISTRATION FOR ALZHEIMER’S DISEASE AND RELATE D DEMENTIAS AND 2 | |
| 100 | - | RELEVANT INFORMATION ON TREATMENT USE AND OUTCOMES, INCLUDING 3 | |
| 101 | - | INFORMATION RELATED TO TREATMENT OUTCOME S BASED ON BIOLOGICA L SEX. 4 | |
| 98 | + | (2) THE HOSPITALIZATION R ATE RELATED TO ALZHEIMER’S DISEASE 1 | |
| 99 | + | AND RELATED DEMENTIA S; AND 2 | |
| 102 | 100 | ||
| 103 | - | 18–111. 5 | |
| 101 | + | (3) TO THE EXTENT POSSIBL E, THE PREVALENCE AND 3 | |
| 102 | + | HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATE D DEMENTIA S 4 | |
| 103 | + | DISAGGREGATED BASED ON: 5 | |
| 104 | 104 | ||
| 105 | - | (A) THE DEPARTMENT , IN COLLABORATION WITH T HE STATE–DESIGNATED 6 | |
| 106 | - | HEALTH INFORMATION E XCHANGE, SHALL ESTABLISH AND MAINTAIN A PUBLICLY 7 | |
| 107 | - | ACCESSIBLE WEBSITE T HAT INCLUDES IN A DO WNLOADABLE FORMAT TH E 8 | |
| 108 | - | FOLLOWING INFORMATIO N: 9 | |
| 105 | + | (I) AGE, INCLUDING AGE OF DIA GNOSIS; 6 | |
| 109 | 106 | ||
| 110 | - | (1) THE PREVALENCE OF ALZHEIMER’S DISEASE AND RELATE D 10 | |
| 111 | - | DEMENTIAS IN THE STATE; 11 | |
| 107 | + | (II) SEX; 7 | |
| 112 | 108 | ||
| 113 | - | (2) THE HOSPITALIZATION R ATE RELATED TO ALZHEIMER’S DISEASE 12 | |
| 114 | - | AND RELATED DEMENTIA S; AND 13 | |
| 109 | + | (III) RACE; 8 | |
| 115 | 110 | ||
| 116 | - | (3) TO THE EXTENT POSSIBL E, THE PREVALENCE AND 14 | |
| 117 | - | HOSPITALIZATION RATE OF ALZHEIMER’S DISEASE AND RELATE D DEMENTIAS 15 | |
| 118 | - | DISAGGREGATED BASED ON: 16 | |
| 111 | + | (IV) ETHNICITY; AND 9 | |
| 119 | 112 | ||
| 120 | - | ( | |
| 113 | + | (V) NUMBER OF C ASES BY COUNTY . 10 | |
| 121 | 114 | ||
| 122 | - | (II) SEX; 18 | |
| 115 | + | (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION 11 | |
| 116 | + | SHALL: 12 | |
| 123 | 117 | ||
| 124 | - | (III) RACE; 19 | |
| 118 | + | (1) INCLUDE THE DATA AVAI LABLE FOR THE IMMEDIATELY 13 | |
| 119 | + | PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND 14 | |
| 125 | 120 | ||
| 126 | - | (IV) ETHNICITY; AND 20 | |
| 121 | + | (2) BE UPDATED ON OR BEFO RE JANUARY 1 EACH YEAR, BEGINNING 15 | |
| 122 | + | IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA . 16 | |
| 127 | 123 | ||
| 128 | - | (V) NUMBER OF CASES BY CO UNTY; 21 | |
| 129 | - | ||
| 130 | - | (VI) CO–OCCURRENCE OF DOWN SYNDROME (TRISOMY–21); 22 | |
| 131 | - | AND 23 | |
| 132 | - | ||
| 133 | - | (VII) TYPE OF DEMENTIA . 24 | |
| 134 | - | ||
| 135 | - | (B) THE WEBSITE REQUIRED UNDER SUBSECTION (A) OF THIS SECTION 25 | |
| 136 | - | SHALL: 26 | |
| 137 | - | ||
| 138 | - | (1) INCLUDE THE DATA AVAI LABLE FOR THE IMMEDI ATELY 27 | |
| 139 | - | PRECEDING 5–YEAR PERIOD ENDING SEPTEMBER 30, 2025; AND 28 | |
| 140 | - | 4 HOUSE BILL 1004 | |
| 141 | - | ||
| 142 | - | ||
| 143 | - | (2) BE UPDATED ON OR BEFO RE JANUARY 1 EACH YEAR, BEGINNING 1 | |
| 144 | - | IN 2027, TO INCLUDE ANY NEWLY AVAILABLE DATA . 2 | |
| 145 | - | ||
| 146 | - | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 3 | |
| 147 | - | October 1, 2025. 4 | |
| 148 | - | ||
| 149 | - | ||
| 150 | - | ||
| 151 | - | ||
| 152 | - | Approved: | |
| 153 | - | ________________________________________________________________________________ | |
| 154 | - | Governor. | |
| 155 | - | ________________________________________________________________________________ | |
| 156 | - | Speaker of the House of Delegates. | |
| 157 | - | ________________________________________________________________________________ | |
| 158 | - | President of the Senate. | |
| 124 | + | SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect 17 | |
| 125 | + | October 1, 2025. 18 |